Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-related Acute Respiratory Distress Syndrome: A Multicenter and Randomized Open-label Clinical Trial

View ORCID ProfileLuis Patricio Maskin, Ignacio Bonelli, Gabriel Leonardo Olarte, Fernando Palizas Jr., Agostina E Velo, María Fernanda Lurbet, Pablo Lovazzano, Sophia Kotsias, Shiry Attie, Ignacio Lopez Saubidet, Natalio D Baredes, Mariano Setten, View ORCID ProfilePablo Oscar Rodriguez
doi: https://doi.org/10.1101/2021.09.15.21263597
Luis Patricio Maskin
1Intensive Care Unit, Hospital Universitario Sede Pombo (Instituto Universitario CEMIC, Centro de Educación Médica e Investigaciones Clínicas), Buenos Aires, Argentina
2Pulmonary Section, CEMIC, Buenos Aires, Argentina
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luis Patricio Maskin
Ignacio Bonelli
3Intensive Care Unit, Hospital Universitario Sede Saavedra (Instituto Universitario CEMIC), Buenos Aires, Argentina
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriel Leonardo Olarte
4Intensive Care Unit, Sanatorio Sagrado Corazón, Buenos Aires, Argentina
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando Palizas Jr.
5Intensive Care Unit, Clínica Bazterrica, Buenos Aires, Argentina
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Agostina E Velo
1Intensive Care Unit, Hospital Universitario Sede Pombo (Instituto Universitario CEMIC, Centro de Educación Médica e Investigaciones Clínicas), Buenos Aires, Argentina
3Intensive Care Unit, Hospital Universitario Sede Saavedra (Instituto Universitario CEMIC), Buenos Aires, Argentina
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María Fernanda Lurbet
1Intensive Care Unit, Hospital Universitario Sede Pombo (Instituto Universitario CEMIC, Centro de Educación Médica e Investigaciones Clínicas), Buenos Aires, Argentina
3Intensive Care Unit, Hospital Universitario Sede Saavedra (Instituto Universitario CEMIC), Buenos Aires, Argentina
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pablo Lovazzano
3Intensive Care Unit, Hospital Universitario Sede Saavedra (Instituto Universitario CEMIC), Buenos Aires, Argentina
PT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophia Kotsias
1Intensive Care Unit, Hospital Universitario Sede Pombo (Instituto Universitario CEMIC, Centro de Educación Médica e Investigaciones Clínicas), Buenos Aires, Argentina
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shiry Attie
3Intensive Care Unit, Hospital Universitario Sede Saavedra (Instituto Universitario CEMIC), Buenos Aires, Argentina
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ignacio Lopez Saubidet
3Intensive Care Unit, Hospital Universitario Sede Saavedra (Instituto Universitario CEMIC), Buenos Aires, Argentina
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalio D Baredes
4Intensive Care Unit, Sanatorio Sagrado Corazón, Buenos Aires, Argentina
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariano Setten
1Intensive Care Unit, Hospital Universitario Sede Pombo (Instituto Universitario CEMIC, Centro de Educación Médica e Investigaciones Clínicas), Buenos Aires, Argentina
PT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pablo Oscar Rodriguez
1Intensive Care Unit, Hospital Universitario Sede Pombo (Instituto Universitario CEMIC, Centro de Educación Médica e Investigaciones Clínicas), Buenos Aires, Argentina
2Pulmonary Section, CEMIC, Buenos Aires, Argentina
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pablo Oscar Rodriguez
  • For correspondence: prodriguez{at}cemic.edu.ar
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Purpose To determine whether high-dose dexamethasone increases the number of ventilator-free days (VFD) among patients with acute respiratory distress syndrome due to coronavirus disease 2019 (C-ARDS)

Materials A multicenter randomized controlled trial in adults with C-ARDS. Patients received 16 mg/d of dexamethasone intravenously for five days followed by 8 mg/d of dexamethasone for five days, or 6 mg/d of dexamethasone intravenously for 10 days.

Results Data from 98 patients who received at least one dose of dexamethasone were analyzed. At 28 days after randomization, there was no difference between high- and low-dose dexamethasone groups in VFD (median, 0 d [interquartile range (IQR) 0–14 d] versus 0 d [IQR 0–1 d]; P=0.231). The cumulative hazard of successful discontinuation from mechanical ventilation was increased by the high-dose treatment (adjusted sub-distribution hazard ratio: 1.84; 95% CI: 1.31 to 2.5; P<0.001). None of the prespecified secondary and safety outcomes showed a significant difference between treatment arms.

Conclusions Among patients with C-ARDS, the use of higher doses of dexamethasone compared with the recommended low-dose treatment did not show an increase in VFD. However, the higher dose significantly improved the time required to liberate them from the ventilator

Clinical Trial Registered: NCT04395105

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04395105

Funding Statement

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved at the Research Ethics Committee of CEMIC (Buenos Aires, Argentina) and by the Argentine Society of Intensive Care Medicine (SATI) Ethics Committee

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

xI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Funding / Support: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

  • Conflicts of interest: None

Data Availability

De-identified data will be available upon request

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 21, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-related Acute Respiratory Distress Syndrome: A Multicenter and Randomized Open-label Clinical Trial
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-related Acute Respiratory Distress Syndrome: A Multicenter and Randomized Open-label Clinical Trial
Luis Patricio Maskin, Ignacio Bonelli, Gabriel Leonardo Olarte, Fernando Palizas Jr., Agostina E Velo, María Fernanda Lurbet, Pablo Lovazzano, Sophia Kotsias, Shiry Attie, Ignacio Lopez Saubidet, Natalio D Baredes, Mariano Setten, Pablo Oscar Rodriguez
medRxiv 2021.09.15.21263597; doi: https://doi.org/10.1101/2021.09.15.21263597
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-related Acute Respiratory Distress Syndrome: A Multicenter and Randomized Open-label Clinical Trial
Luis Patricio Maskin, Ignacio Bonelli, Gabriel Leonardo Olarte, Fernando Palizas Jr., Agostina E Velo, María Fernanda Lurbet, Pablo Lovazzano, Sophia Kotsias, Shiry Attie, Ignacio Lopez Saubidet, Natalio D Baredes, Mariano Setten, Pablo Oscar Rodriguez
medRxiv 2021.09.15.21263597; doi: https://doi.org/10.1101/2021.09.15.21263597

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Intensive Care and Critical Care Medicine
Subject Areas
All Articles
  • Addiction Medicine (431)
  • Allergy and Immunology (757)
  • Anesthesia (221)
  • Cardiovascular Medicine (3298)
  • Dentistry and Oral Medicine (365)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1173)
  • Epidemiology (13385)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5158)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3276)
  • Health Policy (1143)
  • Health Systems and Quality Improvement (1193)
  • Hematology (432)
  • HIV/AIDS (1019)
  • Infectious Diseases (except HIV/AIDS) (14637)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (478)
  • Medical Ethics (127)
  • Nephrology (525)
  • Neurology (4930)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (886)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (728)
  • Orthopedics (282)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (544)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4218)
  • Public and Global Health (7512)
  • Radiology and Imaging (1708)
  • Rehabilitation Medicine and Physical Therapy (1016)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (549)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)